Gensight Biologics (XPAR:SIGHT) YoY EPS Growth : 24.32% (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Gensight Biologics YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Gensight Biologics's YoY EPS Growth for the quarter that ended in Dec. 2023 was 24.32%.

Gensight Biologics's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was €-0.28.

Gensight Biologics YoY EPS Growth Historical Data

The historical data trend for Gensight Biologics's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gensight Biologics YoY EPS Growth Chart

Gensight Biologics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EPS Growth

Get a 7-Day Free Trial

20.44

11.01

35.05

4.76

10.00

Gensight Biologics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
YoY EPS Growth	Get a 7-Day Free Trial															15.38	-21.05	15.91	-13.04	24.32

Gensight Biologics YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Gensight Biologics's YoY EPS Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EPS Growth (A: Dec. 2023 )
=	(Earnings per Share (Diluted) (A: Dec. 2023 )	-	Earnings per Share (Diluted) (A: Dec. 2022 ))	/	\| Earnings per Share (Diluted) (A: Dec. 2022 ) \|
=	(-0.54	-	-0.6)	/	\| -0.6 \|
=	10.00 %

Gensight Biologics's YoY EPS Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY EPS Growth (Q: Dec. 2023 )
=	(Earnings per Share (Diluted) (Q: Dec. 2023 )	-	Earnings per Share (Diluted) (Q: Dec. 2022 ))	/	\| Earnings per Share (Diluted) (Q: Dec. 2022 )) \|
=	(-0.28	-	-0.37)	/	\| -0.37 \|
=	24.32 %

Gensight Biologics YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Gensight Biologics's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Gensight Biologics (XPAR:SIGHT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gensight Biologics SA (XPAR:SIGHT) » Definitions » YoY EPS Growth

Comparable Companies

Traded in Other Exchanges

GSGTF:USA G49N:Germany

Address

74,rue du Faubourg Saint-Antoine, Paris, FRA, 75012

Website

https://www.gensight-biologics.com

Gensight Biologics SA is a clinical-stage biotechnology group discovering and developing novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system. The company's pipeline leverages two core technology platforms, the Mitochondrial Targeting Sequence, and Optogenetics, to help preserve or restore vision in patients suffering from severe degenerative retinal diseases. The group focus is on ophthalmology where it develops product candidates to restore eyesight to patients suffering from retinal diseases. The product candidate, LUMEVOQ, was developed using the MTS technology platform and is designed to treat LHON by restoring the function of retinal diseases resulting from mutations.

Gensight Biologics (XPAR:SIGHT) Headlines

No Headlines